Effects of Kinesio Tape on Delayed Onset Muscle Soreness

Overview

The purpose of this study is to determine the effect of Kinesio tape on delayed onset muscle soreness of the biceps muscle of your arm following strenuous exercise of the bicep muscle.

Detailed description

Participants will complete 4 testing sessions that will be held on 4 separate days (Baseline, Eccentric Exercise day, 48 hours post exercise, and 72 hours post exercise). All sessions will take place in the National Institute of Fitness and Sport, where the Department of Kinesiology laboratories are located.

During the first session (Baseline), the purpose and procedures of the research will be explained by the investigator, co-investigator, or a research assistant in more detail. Participants will read and sign the informed consent form and then undergo an exclusion/inclusion criteria assessment which includes the Physical Activity Readiness Questionnaire (PAR-Q), and brief questionnaire. All study personnel/staff obtaining informed consent will be trained in the responsible conduct of research. All participants will be asked if they have a known allergy to Kinesio Tape (KT) or if they have sensitive skin. Those with sensitive skin will be administered an allergy test. After screening and enrollment, participants will complete baseline assessments of muscle pain and function, pain sensitivity, and psychological risk factors (See outcome measures).

During Session 2, strength of the non-dominant bicep will be measured first. Participants will then perform an eccentric exercise protocol designed to induce delayed onset muscle soreness (DOMS) on the non-dominant arm. Strength of the non-dominant bicep will be measured immediately post the eccentric exercise protocol. At the end of this session, subjects will be randomly assigned to one of two intervention groups (experimental KT group, placebo KT group) or a control group (i.e., no intervention performed). The experimental group will receive KT with proper technique and tension (10-20%), while the placebo group will receive KT without technique and tension.

Sessions 3 and 4 will occur approximately 48 and 72 hours post Session 2, respectively. All the outcome variables will be measured during these sessions. For participants in the KT groups, the tape will be removed at the end of session 4, as described below.

Interventions

• Device Kinesiotape
  Tape will be applied to the biceps muscle of the nondominant arm from approximately the shoulder to the elbow for up to 72 hours. For the KT group taping will be applied with a lymphatic application method according to the guidelines recommended by Kenzo Kase. This type of application is known to improve blood and lymphatic circulation which enhances the removal of metabolic products. It is recommended that the application of the tape for lymphatic correction be applied for 24-72 hours. The tape

Primary outcome measures

• change in worst pain in previous 24 hours [Time frame: This measure will be assessed at baseline and 48 hours and 72 hours following completion of the eccentric exercise protocol]
• Change in average pain in previous 24 hours [Time frame: This measure will be assessed at baseline and 48 hours and 72 hours following completion of the eccentric exercise protocol]
• Change in pain during elbow extension and elbow flexion [Time frame: This measure will be assessed at baseline and 48 hours and 72 hours following completion of the eccentric exercise protocol]
• Change in pressure pain threshold of the affected biceps [Time frame: This measure will be assessed at baseline and 48 hours and 72 hours following completion of the eccentric exercise protocol]
• Change in Active Total Elbow Range of Motion (AT-ROM) [Time frame: This measure will be assessed at baseline and 48 hours and 72 hours following completion of the eccentric exercise protocol]
• Change in pain during elbow flexion and extension [Time frame: This measure will be assessed at baseline and 48 hours and 72 hours following completion of the eccentric exercise protocol]
• Change in Maximal Strength of non-dominant bicep. [Time frame: This measure will be assessed at baseline and 48 hours and 72 hours following completion of the eccentric exercise protocol]

Secondary outcome measures (3)

• Change in Self-reported function of the affected arm [Time frame: This measure will be assessed at baseline and 48 hours and 72 hours following completion of the eccentric exercise protocol]
• Pain catastrophizing [Time frame: This instrument will be administered at baseline]
• Fear of movement or reinjury [Time frame: This instrument will be administered at baseline]

Eligibility criteria

Inclusion criteria

• 18 to 30 years old

Exclusion criteria

• Participating in any strengthening exercises or activities of the upper extremities for the past month.
• Regularly (\~2x per month) participating in strengthening exercises or activities that include lengthening actions of the upper extremity for the past 6 months.
• An answer of yes to any of the seven questions on the first page of the 2019 Physical Activity Readiness Questionnaire \[PAR-Q: 16\] indicating that the subject is not physically ready for exercise without a medical exam. These exclusions include the following:

• If participant's doctor has ever said that he/she has a heart condition or high blood pressure
• Pain in chest at rest, during daily activities of living, or when doing physical activity
• If participant has ever lost balance because of dizziness or has lost consciousness in the past 12 months
• If the participant currently has (or have had within the past 12 months) a bone, joint, or soft tissue (muscle, ligament, or tendon) problem that could be made worse by becoming more physically activity
• If participant is currently taking prescribed medications for a chronic medical condition
• If the participant's doctor has ever told them that they should only do medically supervised physical activity.
• Currently taking nutritional supplements or anti-inflammatory medication on a daily basis
• Any injury or surgery to the neck or upper extremity in the past 6 months
• Open or scabbed wounds in the arm area to be taped
• Known allergies to the tape or medical adhesive bandages
• If skin irritation develops to the tape

Session exclusion criteria:

● Taking over-the-counter pain medications on days of testing, prior to testing sessions, including acetaminophen (Tylenol) and nonsteroidal inflammatory drugs (NSAIDs), including ibuprofen (Motrin, Advil) or naproxen (Aleve, Naprosyn).

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation

Randomized

Model

Parallel assignment

Masking

Single blind

Primary purpose

Treatment

Study locations

United States · 1 center

• Indiana University Purdue University Indianapolis — Indianapolis

Identifiers

NCT: NCT04128670 · 1908530527

Primary sources (government registries)

• ClinicalTrials.gov (US NIH)

View this study on ClinicalTrials.gov ↗